Afya Limited (NASDAQ:AFYA) Given Average Recommendation of “Hold” by Brokerages

Shares of Afya Limited (NASDAQ:AFYA) have received an average recommendation of “Hold” from the eight brokerages that are presently covering the firm, MarketBeat.com reports. Seven analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $17.10.

Several research analysts have weighed in on AFYA shares. Zacks Research lowered shares of Afya from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 6th. JPMorgan Chase & Co. decreased their price target on Afya from $21.50 to $21.00 and set a “neutral” rating on the stock in a research note on Monday, June 22nd. Weiss Ratings restated a “hold (c)” rating on shares of Afya in a report on Monday, April 20th. Bank of America reaffirmed a “neutral” rating on shares of Afya in a research note on Thursday, June 11th. Finally, Wall Street Zen downgraded Afya from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 2nd.

Afya Price Performance

Shares of AFYA traded down $0.10 during trading hours on Friday, reaching $14.38. The company had a trading volume of 63,386 shares, compared to its average volume of 121,278. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.42. Afya has a 12-month low of $13.00 and a 12-month high of $16.50. The firm has a 50 day simple moving average of $14.33 and a 200-day simple moving average of $14.54. The company has a market capitalization of $1.35 billion, a price-to-earnings ratio of 9.40, a PEG ratio of 1.43 and a beta of 0.32.

Insider Transactions at Afya

In other news, insider Santos Welder Ferreira sold 3,325 shares of Afya stock in a transaction on Friday, April 17th. The stock was sold at an average price of $15.90, for a total transaction of $52,867.50. Following the completion of the transaction, the insider owned 35,000 shares of the company’s stock, valued at $556,500. The trade was a 8.68% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, VP Lelio De Souza Junior sold 41,541 shares of the business’s stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $15.00, for a total transaction of $623,115.00. Following the completion of the sale, the vice president owned 36,204 shares in the company, valued at $543,060. This represents a 53.43% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 105,070 shares of company stock worth $1,582,782. Corporate insiders own 0.80% of the company’s stock.

Institutional Trading of Afya

Institutional investors and hedge funds have recently modified their holdings of the business. Swedbank AB increased its position in Afya by 170.3% during the fourth quarter. Swedbank AB now owns 189,200 shares of the company’s stock worth $2,916,000 after buying an additional 119,200 shares in the last quarter. Doma Perpetual Capital Management LLC lifted its position in shares of Afya by 50.6% in the third quarter. Doma Perpetual Capital Management LLC now owns 891,639 shares of the company’s stock valued at $13,910,000 after acquiring an additional 299,419 shares in the last quarter. Daiwa Securities Group Inc. purchased a new stake in shares of Afya in the fourth quarter valued at $43,000. Squarepoint Ops LLC acquired a new stake in shares of Afya during the third quarter valued at $191,000. Finally, Van ECK Associates Corp boosted its stake in shares of Afya by 15.7% during the third quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock valued at $159,000 after acquiring an additional 1,377 shares during the last quarter. Hedge funds and other institutional investors own 88.02% of the company’s stock.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.